相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor Presence Induces Global Immune Changes and Enhances Nanoparticle Clearance
Marc P. Kai et al.
ACS NANO (2016)
Shooting for the Moon: Nanoscale Approaches to Cancer
Paula T. Hammond
ACS NANO (2016)
Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
Jinho Park et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing
Samantha M. Sarett et al.
BIOMATERIALS (2016)
An albumin-mediated cholesterol design-based strategy for tuning siRNA pharmacokinetics and gene silencing
Konrad Bienk et al.
JOURNAL OF CONTROLLED RELEASE (2016)
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
F. Danhier
JOURNAL OF CONTROLLED RELEASE (2016)
CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing
Andrew J. Clark et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding
Haojun Chen et al.
THERANOSTICS (2016)
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
John D. Martin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
Shigeo Matsuda et al.
ACS CHEMICAL BIOLOGY (2015)
Efficient Synthesis and Biological Evaluation of 5′-GalNAc Conjugated Antisense Oligonucleotides
Michael E. Ostergaard et al.
BIOCONJUGATE CHEMISTRY (2015)
Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers
Martina Miteva et al.
BIOMATERIALS (2015)
Nanomedicines Targeting the Tumor Microenvironment
Rong Tong et al.
CANCER JOURNAL (2015)
Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
Jurre J. Kamphorst et al.
CANCER RESEARCH (2015)
Hepatocyte-Specific Delivery of siRNAs Conjugated to Novel Non-nucleosidic Trivalent N-Acetylgalactosamine Elicits Robust Gene Silencing in Vivo
Kallanthottathil G. Rajeev et al.
CHEMBIOCHEM (2015)
Conjugation of palmitic acid improves potency and longevity of siRNA delivered via endosomolytic polymer nanoparticles
Samantha M. Sarett et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2015)
Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation
Kevin G. Reuter et al.
NANO LETTERS (2015)
Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
Xi Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
Ki Young Choi et al.
ACS NANO (2014)
Liposomal siRNA nanocarriers for cancer therapy
Bulent Ozpolat et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
A Physiological Perspective on the Use of Imaging to Assess the In Vivo Delivery of Therapeutics
Shengping Qin et al.
ANNALS OF BIOMEDICAL ENGINEERING (2014)
Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier
Yijie Chen et al.
BIOMATERIALS (2014)
Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors
Yusuke Oe et al.
BIOMATERIALS (2014)
EPR: Evidence and fallacy
Joseph W. Nichols et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate
Min Sang Lee et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action
Odile E. Levy et al.
PLOS ONE (2014)
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
Jonathan E. Zuckerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Yizhou Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
Uma Prabhakar et al.
CANCER RESEARCH (2013)
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
Mark J. Ernsting et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
Scott Eliasof et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Amino-Modified and Lipid-Conjugated Dicer-Substrate siRNA Enhances RNAi Efficacy
Takanori Kubo et al.
BIOCONJUGATE CHEMISTRY (2012)
Poly(PS-b-DMA) micelles for reactive oxygen species triggered drug release
Mukesh K. Gupta et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Enhanced Extravasation, Stability and in Vivo Cardiac Gene Silencing via in Situ siRNA-Albumin Conjugation
Shannen Lau et al.
MOLECULAR PHARMACEUTICS (2012)
Harnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles
Tomoko Nakayama et al.
MOLECULAR THERAPY (2012)
Progress Toward In Vivo Use of siRNAs-II
Garrett R. Rettig et al.
MOLECULAR THERAPY (2012)
Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane
Jonathan E. Zuckerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Jinjun Shi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
The modification of siRNA with 3′ cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes
Vishakha V. Ambardekar et al.
BIOMATERIALS (2011)
Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA2 Repression of Slit2 Tumor Suppressor Function in Endothelium
Dana M. Brantley-Sieders et al.
CANCER RESEARCH (2011)
High-Density Lipoprotein Facilitates In Vivo Delivery of α-Tocopherol-Conjugated Short-Interfering RNA to the Brain
Yoshitaka Uno et al.
HUMAN GENE THERAPY (2011)
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Efficient In Vivo Delivery of siRNA Into Brain Capillary Endothelial Cells Along With Endogenous Lipoprotein
Hiroya Kuwahara et al.
MOLECULAR THERAPY (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Cliff Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Native albumin for targeted drug delivery
Elena Neumann et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2008)
Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin
Abraham Ami Sidi et al.
JOURNAL OF UROLOGY (2008)
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
Marina A. Dobrovolskaia et al.
MOLECULAR PHARMACEUTICS (2008)
Chemical Modification of siRNAs for In Vivo Use
Mark A. Behlke
OLIGONUCLEOTIDES (2008)
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Christian Wolfrum et al.
NATURE BIOTECHNOLOGY (2007)
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
Derek W. Bartlett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity
Saghir Akhtar et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Toxicity of cationic lipids and cationic polymers in gene delivery
Hongtao Lv et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells
C Lorenz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
Nile red and DCM fluorescence Anisotropy studies in C12E7/DPPC mixed systems
PJG Coutinho et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2002)
分享论文
